Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) Sees Significant Growth in Short Interest

Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) was the recipient of a large increase in short interest in the month of February. As of February 28th, there was short interest totalling 700 shares, an increase of 16.7% from the February 13th total of 600 shares. Based on an average daily volume of 17,100 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the stock are short sold.

Tema Cardiovascular and Metabolics ETF Price Performance

Shares of NASDAQ:HRTS opened at $30.13 on Friday. The firm has a fifty day moving average price of $30.03 and a two-hundred day moving average price of $31.61. Tema Cardiovascular and Metabolics ETF has a one year low of $28.56 and a one year high of $36.03. The company has a market cap of $69.30 million, a price-to-earnings ratio of 32.63 and a beta of 0.93.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Tema Cardiovascular and Metabolics ETF stock. Sterling Investment Advisors Ltd. lifted its stake in shares of Tema Cardiovascular and Metabolics ETF (NASDAQ:HRTS) by 5.7% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 167,703 shares of the company’s stock after acquiring an additional 9,008 shares during the period. Tema Cardiovascular and Metabolics ETF makes up 1.2% of Sterling Investment Advisors Ltd.’s investment portfolio, making the stock its 24th biggest position. Sterling Investment Advisors Ltd. owned about 7.29% of Tema Cardiovascular and Metabolics ETF worth $4,842,000 as of its most recent filing with the SEC.

About Tema Cardiovascular and Metabolics ETF

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive.